Drug Regulatory Authority of Pakistan (DRAP) has warned the Ministry of Health against administering Sinopharm’s COVID-19 vaccine to people with a weak
China’s 3rd vaccine enters Pakistan
National
February 15, 2021
ISLAMABAD: Pakistan has become the 1st country in the whole world as a recipient of the third Chinese vaccine “ZF2001” to boost up its COVID-19 vaccination drive, Gwadar Pro reported on Sunday.
Before, Pakistan has already welcomed CanSino and Sinopharm.The third Chinese Vaccine is being co-developed by Anhui Zhifei Longcom Biologic Pharmacy Co. Ltd, and the Institute of Microbiology of the Chinese Academy of Sciences. Drug Regulatory Authority of Pakistan (DRAP) has approved ZF2001’s last stage trails usually called Phase III Clinical Trials in order to pave its way for emergency use authentication shortly. University of Health SciDr Shehnoor Azhar said,“With its reliability and performance against new COVID-19 variants, it seems to be very effective in triggering immunity response.”
The government has approved China’s CanSinoBio Covid-19 vaccine for emergency use in Pakistan, Special Assistant to the Prime Minister on Health Dr. Faisal Sultan said on Friday.
Drug Regulatory Authority of Pakistan (DRAP) has already approved three other vaccines for use in Pakistan - China s Sinopharm, Russia s Sputnik-V and the Oxford University-AstraZeneca vaccine. Drap officials said that after its approval for emergency use, the supply of the doses will start in a few weeks.
Cansino Bio is the only vaccine for which Pakistan conducted a clinical trial, with around 18,000 volunteers participating from across the country.
The analysis, which was released by the Independent Data Monitoring Committee (IDMC), showed that it had 74.48 per cent efficacy rate in preventing symptomatic cases and 100 per cent in preventing severe disease.
KARACHI (Sputnik) - Pakistan would be happy to look into prospects of establishing production lines of Russia s Sputnik V vaccine on its territory, Pakistan s Minister.
Another Chinese vaccine gets nod for emergency use in Pakistan
The Drug Regulatory Authority of Pakistan has issued emergency use authorization to the COVID-19 vaccine by Chinese company Cansino Biologics Inc.
| 14 Feb 2021 8:18 AM GMT
ISLAMABAD: The Drug Regulatory Authority of Pakistan (Drap) has issued emergency use authorization to the COVID-19 vaccine by Chinese company Cansino Biologics Inc, officials said, adding the supply of the doses will begin in a few weeks.
It will become the fourth vaccine to be allowed for emergency use in Pakistan, the Dawn news reported.
Cansino Biologics Inc is the only company that has conducted clinical trials in Pakistan, with around 18,000 volunteers participating from across the country.